# Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent Miscarriage

> **NCT00722475** · PHASE3 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 82 (actual)

## Conditions studied

- Secondary Recurrent Miscarriage

## Interventions

- **DRUG:** Intravenous immunoglobulin
- **DRUG:** Human albumin

## Key facts

- **NCT ID:** NCT00722475
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2014-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00722475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00722475, "Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent Miscarriage". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00722475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*